المؤلفون: Pozhidaev, I., Alifirova, V.M., Freidin, M.B., Zhukova, I.A., Fedorenko, O.Y., Osmanova, D.Z., Mironova, Y.S., Wilffert, B., Ivanova, S.A., Loonen, A.J.M.

المصدر: Pozhidaev , I , Alifirova , V M , Freidin , M B , Zhukova , I A , Fedorenko , O Y , Osmanova , D Z , Mironova , Y S , Wilffert , B , Ivanova , S A & Loonen , A J M 2017 , ' Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia ' , European Neuropsychopharmacology , vol. 27 , no. Supplement 4 , pp. S590 . https://doi.org/10.1016/S0924-977XTest(17)31129-X

مصطلحات موضوعية: biological marker, dopamine 2 receptor, dopamine 3 receptor, dopamine 4 receptor, endogenous compound, levodopa, phosphodiesterase I, Abnormal Involuntary Movement Scale, adult, adverse event, analyzer, cohort analysis, data analysis software, DNA extraction, drug metabolism, drug therapy, female, gender, gene frequency, gene mutation, genetic marker, genetic susceptibility, genotype, human, levodopa-induced dyskinesia, major clinical study, male, onset age, oxidative stress, Parkinson disease

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/49c63eae-168b-434c-a8e6-8245566e6df3Test

الإتاحة: https://doi.org/10.1016/S0924-977XTest(17)31129-X
https://hdl.handle.net/11370/49c63eae-168b-434c-a8e6-8245566e6df3Test
https://research.rug.nl/en/publications/49c63eae-168b-434c-a8e6-8245566e6df3Test
https://pure.rug.nl/ws/files/50464436/1_s2.0_S0924977X1731129X_main.pdfTest

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المصدر: Ivanova , S A , Alifirova , V M , Pozhidaev , I V , Fedorenko , O Y , Osmanova , D Z , Tiguntsev , V V , Bokhan , N A , Zhukova , I A , Wilffert , B & Loonen , A J M 2016 , ' CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias ' , European Neuropsychopharmacology , vol. 26 , pp. S656-S657 .

مصطلحات موضوعية: antioxidant, catechol methyltransferase, cytochrome P450 2D6, dopamine, endogenous compound, levodopa, methionine, neurotransmitter, neurotransmitter receptor, phosphodiesterase I, Abnormal Involuntary Movement Scale, adverse drug reaction, clinical trial, codon, data analysis software, disease carrier, disease duration, DNA extraction, dopamine uptake, drug therapy, gene frequency, genetic susceptibility, genotype, human, levodopa-induced dyskinesia, major clinical study, missense mutation, monoamine metabolism, odds ratio, onset age

العلاقة: https://research.rug.nl/en/publications/014e8ece-6d80-4997-9468-60cc28f28dd2Test

الإتاحة: https://hdl.handle.net/11370/014e8ece-6d80-4997-9468-60cc28f28dd2Test
https://research.rug.nl/en/publications/014e8ece-6d80-4997-9468-60cc28f28dd2Test

المؤلفون: Ivanova, S.A., Alifirova, V.M., Fedorenko, O.Y., Freidin, M.B., Bokhan, N.A., Zhukova, I., Al Hadithy, A.F.Y., Brouwers, J.R.B.J., Wilffert, B., Loonen, A.J.M.

المصدر: Ivanova , S A , Alifirova , V M , Fedorenko , O Y , Freidin , M B , Bokhan , N A , Zhukova , I , Al Hadithy , A F Y , Brouwers , J R B J , Wilffert , B & Loonen , A J M 2015 , ' Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease ' , European Neuropsychopharmacology , vol. 25 , no. Supplement 2 , Abstract poster , pp. S589 . https://doi.org/10.1016/S0924-977XTest(15)30828-2

مصطلحات موضوعية: levodopa, serotonin receptor, neurotransmitter receptor, DOPA, dopamine, enzyme, dopamine receptor, n methyl dextro aspartic acid receptor, antioxidant, protein, phosphodiesterase I, DNA, n methyl dextro aspartic acid, levodopa-induced dyskinesia, gene, college, psychopharmacology, European, Parkinson disease, human, dyskinesia, limb, patient, phenotype, genotype, risk, drug metabolism, single nucleotide polymorphism, Abnormal Involuntary Movement Scale, receptor gene

العلاقة: https://research.rug.nl/en/publications/923bb3a0-8365-4859-9f95-d460994d28cbTest

الإتاحة: https://doi.org/10.1016/S0924-977XTest(15)30828-2
https://hdl.handle.net/11370/923bb3a0-8365-4859-9f95-d460994d28cbTest
https://research.rug.nl/en/publications/923bb3a0-8365-4859-9f95-d460994d28cbTest

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المساهمون: Methods in Medicines evaluation & Outcomes research (M2O), Reproductive Origins of Adult Health and Disease (ROAHD), PharmacoTherapy, -Epidemiology and -Economics, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

المصدر: ResearcherID
European Neuropsychopharmacology, 26, S656-S657. ELSEVIER SCIENCE BV

مصطلحات موضوعية: onset age, antioxidant, side effect, endogenous compound, phenotype, neurotransmitter receptor, genotype, adverse drug reaction, prevalence, gene frequency, disease carrier, statistical analysis, single nucleotide polymorphism, dopamine uptake, odds ratio, oxidative stress, human, levodopa, DNA extraction, cytochrome P450 2D6, Abnormal Involuntary Movement Scale, methionine, phosphodiesterase I, data analysis software, missense mutation, levodopa-induced dyskinesia, treatment response, clinical trial, visually impaired person, major clinical study, drug therapy, monoamine metabolism, Parkinson disease, catechol methyltransferase, substitution reaction, dopamine, codon, disease duration, neurotransmitter, genetic susceptibility

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::08382109854c93ef19f47098e58d290cTest
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000398568302345&KeyUID=WOS:000398568302345Test